Chia-yang Hsu, MD | |
75 Pringle Way Ste 701, Reno, NV 89502-1472 | |
(775) 982-5000 | |
(775) 982-3900 |
Full Name | Chia-yang Hsu |
---|---|
Gender | Male |
Speciality | Internal Medicine - Gastroenterology |
Location | 75 Pringle Way Ste 701, Reno, Nevada |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609260892 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | 4301115155 (Michigan) | Secondary |
207RG0100X | Internal Medicine - Gastroenterology | 21267 (Nevada) | Primary |
Entity Name | Community Care Services Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1720031768 PECOS PAC ID: 1951324318 Enrollment ID: O20060111000900 |
News Archive
Shannon Carson, MD, professor of medicine and division chief of Pulmonary Diseases and Critical Care Medicine at the UNC School of Medicine, along with co-principal investigator Judith Nelson, MD, JD, at Memorial Sloan Kettering Cancer Center, and Christopher Cox, MD, of Duke University, led a four-year, first-of-its kind clinical study on the effects of palliative care for medical decision-makers.
For many newborn babies, an enzyme that breaks down the molecule bilirubin doesn't activate right away. The resulting bilirubin buildup can lead to jaundice, a typically harmless condition that causes a baby's skin to temporarily appear yellow.
A neurofeedback system enables Parkinson's disease patients to voluntarily control brainwaves associated with symptoms of the disorder, according to new research published in eNeuro. It remains to be determined whether such a system can provide symptom relief.
The PATH Malaria Vaccine Initiative (MVI) announced today that it has entered into a collaboration with Dutch biopharmaceutical company Crucell N.V. and GlaxoSmithKline (GSK). This collaboration is aimed at developing a second-generation vaccine against malaria—a deadly disease that kills close to 800,000 people annually, most of them young children under age five in Africa. MVI drives the development of malaria vaccines by joining its scientific, managerial, and field expertise with companies, universities, and governments to test potential malaria vaccines and invest in those with the most promise.
A landmark study published in the New England Journal of Medicine today heralds a new era in stroke treatment across the globe.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Chia-yang Hsu, MD 1155 Mill St # M14, Reno, NV 89502-1576 Ph: (775) 982-5262 | Chia-yang Hsu, MD 75 Pringle Way Ste 701, Reno, NV 89502-1472 Ph: (775) 982-5000 |
News Archive
Shannon Carson, MD, professor of medicine and division chief of Pulmonary Diseases and Critical Care Medicine at the UNC School of Medicine, along with co-principal investigator Judith Nelson, MD, JD, at Memorial Sloan Kettering Cancer Center, and Christopher Cox, MD, of Duke University, led a four-year, first-of-its kind clinical study on the effects of palliative care for medical decision-makers.
For many newborn babies, an enzyme that breaks down the molecule bilirubin doesn't activate right away. The resulting bilirubin buildup can lead to jaundice, a typically harmless condition that causes a baby's skin to temporarily appear yellow.
A neurofeedback system enables Parkinson's disease patients to voluntarily control brainwaves associated with symptoms of the disorder, according to new research published in eNeuro. It remains to be determined whether such a system can provide symptom relief.
The PATH Malaria Vaccine Initiative (MVI) announced today that it has entered into a collaboration with Dutch biopharmaceutical company Crucell N.V. and GlaxoSmithKline (GSK). This collaboration is aimed at developing a second-generation vaccine against malaria—a deadly disease that kills close to 800,000 people annually, most of them young children under age five in Africa. MVI drives the development of malaria vaccines by joining its scientific, managerial, and field expertise with companies, universities, and governments to test potential malaria vaccines and invest in those with the most promise.
A landmark study published in the New England Journal of Medicine today heralds a new era in stroke treatment across the globe.
› Verified 1 days ago
Dr. Richard Bruce Rosen, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 781 Mill St, Reno, NV 89502 Phone: 775-398-1980 Fax: 775-398-1981 | |
Rahul Navin Mediwala, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1500 E 2nd St, Suite 201, Reno, NV 89502 Phone: 775-982-3355 Fax: 775-982-3356 | |
Dr. Raymond Hill Scott Iii, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 330 Crampton St, Reno, NV 89502 Phone: 775-336-3700 Fax: 775-336-3701 | |
Dr. Bruce William Denney, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1155 Mill St Ms W14, Reno, NV 89502 Phone: 775-982-7878 Fax: 775-982-4196 | |
Dr. Elmer Epres Alegre, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1715 Kuenzli St, Reno, NV 89502 Phone: 775-329-5162 Fax: 775-334-4356 | |
Dr. Devang Mahesh Desai, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 645 N Arlington Ave Ste 555, Reno, NV 89503 Phone: 775-770-7622 Fax: 775-770-3683 | |
Dr. Louis Christopher Tripoli, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 1510 Meadow Wood Ln, Prominence Health, Reno, NV 89502 Phone: 775-770-9242 Fax: 928-832-2864 |